D. Brockmeier

发表

Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants.

Michel Eichelbaum, Dorothee Wernet, M. Eichelbaum, 2004, Pharmacogenetics.

Mean residence time.

D. Brockmeier, H. M. von Hattingberg, 1986, Methods and findings in experimental and clinical pharmacology.

Why Escherichia coli α‐hemolysin induces calcium oscillations in mammalian cells‐the pore is on its own

S. Bhakdi, H. Repp, D. Brockmeier, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Absorption of glibenclamide from different sites of the gastro-intestinal tract

D. Brockmeier, H. Leonhardt, H. Grigoleit, 2004, European Journal of Clinical Pharmacology.

Listeriolysin of Listeria monocytogenes forms Ca2+‐permeable pores leading to intracellular Ca2+ oscillations

E. Domann, T. Chakraborty, A. Darji, 2002, Cellular microbiology.

Interactions of sildenafil and tacrolimus in men with erectile dysfunction after kidney transplantation.

D. Brockmeier, S. Friemann, E. Hauck, 2001, Urology.

Penbutolol: Pharmacokinetics, effect on exercise tachycardia, and in vitro inhibition of radioligand binding

A. Wellstein, D. Brockmeier, E. Mutschler, 2004, European Journal of Clinical Pharmacology.

The pharmacokinetic basis of optimal antibiotic dosage

D. Brockmeier, H. M. Hattingberg, 2005, Infection.

In vitro — In vivo correlation of dissolution, a time scaling problem? Transformation of in vitro results to the in vivo situation, using theophylline as a practical example

H. Dengler, D. Brockmeier, D. Voegele, 2004, European Journal of Clinical Pharmacology.

In vitro--in vivo correlation, a time scaling problem? Basic techniques for testing equivalence.

D. Brockmeier, H. M. von Hattingberg, D. Voegele, 1983, Arzneimittel-Forschung.

Pharmacokinetics of histamine (H2)-receptor antagonists, including roxatidine, in chronic renal failure.

N. Lameire, D. Brockmeier, B. Rosenkranz, 1988, Scandinavian journal of gastroenterology. Supplement.

The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes.

D. Schrenk, M. Eichelbaum, K. Bock, 1994, Pharmacogenetics.

In vitro/in vivo correlation of dissolution using moments of dissolution and transit times

D. Brockmeier, 1986 .

Substrate affinity of the protein tyrosine kinase pp60c-src is increased on thrombin stimulation of human platelets.

D. Brockmeier, P. Presek, U. Liebenhoff, 1993, The Biochemical journal.

Estimating reduced availability due to first pass elimination from relative total clearance and renal clearance

D. Brockmeier, 2004, European Journal of Clinical Pharmacology.

Pharmacokinetic profile of cefodizime

D. Brockmeier, E. Dagrosa, 2005, Infection.

A Pharmacokinetic Study of Roxatidine Acetate in Chronic Renal Failure

N. Lameire, D. Brockmeier, B. Rosenkranz, 2012, Drugs.

A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers

D. Schrenk, M. Eichelbaum, K. Bock, 1998, European Journal of Clinical Pharmacology.

Evidence for muscarinic receptors in endothelial cells from combined functional and binding studies.

D. Brockmeier, W. Kukovetz, E. Kühberger, 1990, European journal of pharmacology.

Properties of agonist binding at theβ-adrenoceptor of the rat reticulocyte

A. Wellstein, G. Wiemer, D. Brockmeier, 1982, Naunyn-Schmiedeberg's Archives of Pharmacology.

A rotating iterative procedure (RIP) for estimating hybrid constants in multi-compartment analysis on desk computers

D. Brockmeier, H. M. Hattingberg, G. Kreuter, 2004, European Journal of Clinical Pharmacology.

The absorption of piretanide from the gastro-intestinal tract is site-dependent

D. Brockmeier, H. Leonhardt, H. Grigoleit, 2004, European Journal of Clinical Pharmacology.

Pharmacokinetic profile of a novel slow release preparation of molsidomine

S. Rietbrock, D. Brockmeier, P. Thürmann, 2006, European Journal of Clinical Pharmacology.

In vivo relevance of a controlled oral release system of Molsidomine

M. Stauch, D. Brockmeier, J. Ostrowski, 1985 .

In vitro-in vivo correlation, a time scaling problem? Evaluation of mean times.

D. Brockmeier, 1984, Arzneimittel-Forschung.

Pharmacokinetic characteristics of roxatidine.

D. Brockmeier, W. Bender, 1989, Journal of clinical gastroenterology.

Mean time and first-pass metabolism

D. Brockmeier, J. Ostrowski, 2004, European Journal of Clinical Pharmacology.

Pharmacokinetics of an extended-release dosage form of molsidomine in patients with coronary heart disease

D. Brockmeier, G. Gaul, J. Ostrowski, 2004, European Journal of Clinical Pharmacology.

Characterization of cyclosporine a uptake in human erythrocytes

H. Dengler, C. Reichel, D. Brockmeier, 2004, European Journal of Clinical Pharmacology.

Site‐Dependent Small Intestinal Absorption of the Ace Inhibitor Ramipril

D. Brockmeier, M. Seibert-Grafe, T. Gramatté, 1996 .

Investigation on interaction between tacrolimus and sildenafil in kidney-transplanted patients with erectile dysfunction.

D. Brockmeier, E. Hauck, B. Christ, 2004, International journal of clinical pharmacology and therapeutics.

In vitro--in vivo correlation, a time scaling problem? Basic considerations on in vitro dissolution testing.

D. Brockmeier, H. M. von Hattingberg, 1982, Arzneimittel-Forschung.